Medtronic (NYSE:MDT) applied for pre-market approval from the FDA for a medical device designed to treat peripheral artery disease, the In.Pact Admiral drug-eluting balloon.
Fridley, Minn.-based Medtronic said it’s gearing up for a full launch in the U.S. in 2015, assuming the FDA approves the application.